New eye drop aims to soothe dry eyes from too much screen time

NCT ID NCT07679685

Not yet recruiting Symptom relief Sponsor: Beijing Tongren Hospital Source: ClinicalTrials.gov ↗

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study compares a new eye drop (perfluorohexyloctane) with a standard one (sodium hyaluronate) for people whose eyes get dry from using screens for more than 6 hours a day. Participants aged 18 to 70 with mild to moderate dry eye will use the drops four times daily for 8 weeks. The main goal is to see if the new drop improves tear film stability better than the standard treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: perfluorohexyloctane eye drops
What this could lead to: If effective, this could offer a new option for people whose eyes feel dry and irritated from long hours on computers or phones.
What could go wrong: This is a Phase 4 trial with 159 participants, so results may not apply to everyone. The new drops might not work better than existing treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRY EYE

Contacts and locations

Locations

Beijing Aier-Intech Eye Hospital

Beijing, China
Beijing Anzhen Hospital

Beijing, Beijing Municipality, China
Chinese PLA General Hospital

Beijing, China
Eye & ENT Hospital of Fudan University

Shanghai, China
Guangdong Provincial People's Hospital

Guangzhou, China
Peking Union Medical College Hospital

Beijing, China
Sun Yat-sen Memorial Hospital

Guangzhou, China
Xi'an Fourth Hospital

Xi'an, China
Zhongshan City People's Hospital

Zhongshan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.